Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» pancreatic cancer
pancreatic cancer
Abraxane Cancer Trials Help Justify Celgene Buyout
investors.com
Sat, 11/17/12 - 02:03 pm
Abraxane
Celgene
pancreatic cancer
Is Threshold on the Threshold of Something Big?
Motley Fool
Fri, 11/16/12 - 10:34 am
Threshold Pharmaceuticals
TH-302
pancreatic cancer
2 Reasons You Should Love This Biotech's Good News
Motley Fool
Tue, 11/13/12 - 11:12 am
Celgene
pancreatic cancer
Abraxane
Celgene Rises as Abraxane Meets Pancreatic Cancer Goals
Bloomberg
Mon, 11/12/12 - 10:57 am
Celgene
pancreatic cancer
Abraxane
Survey Of The Pancreatic Cancer Drug Market With Celgene's Abraxane In Focus
Seeking Alpha
Sun, 11/11/12 - 09:56 am
pancreatic cancer
Celgene
Abraxane
Abraxane Demonstrates Statistically Significant Improvement in Overall Survival for Patients with Advanced Pancreatic Cancer in Phase III Study
Yahoo/BusinessWire
Sat, 11/10/12 - 08:25 am
Abraxane
pancreatic cancer
Celgene's Abraxane Is Talk of European Cancer Confab
TheStreet.com
Mon, 10/1/12 - 10:39 am
Celgene
Abraxane
pancreatic cancer
Celgene CVR: Upside Into Abraxane Pancreatic Cancer Trial Data
TheStreet.com
Tue, 09/25/12 - 11:37 am
Celgene
Abraxane
pancreatic cancer
Threshold's Pancreatic Cancer Drug Boosts Survival -- With an Asterisk
TheStreet.com
Mon, 09/17/12 - 11:01 am
pancreatic cancer
Threshold Pharmaceuticals
TH-302
Amgen Ends Ganitumab Study on Panel Recommendation
NASDAQ.com
Thu, 08/9/12 - 11:34 am
Ganitumab
Amgen
pancreatic cancer
Threshold Pharmaceuticals: TH-302 Phase IIb Clinical Results In First-Line Pancreatic Cancer
Seeking Alpha
Sat, 04/28/12 - 12:43 pm
TH-302
pancreatic cancer
Threshold Pharmaceuticals
Threshold Scores Big With Pancreatic Cancer Data
Seeking Alpha
Mon, 03/5/12 - 11:08 am
pancreatic cancer
Threshold Pharmaceuticals
TH-302
Amgen
Array Biopharma
Micromet
Merck
Pharmacyclics
Threshold Pharmaceuticals: Understanding The Recent Data
Seeking Alpha
Wed, 02/29/12 - 11:07 am
Threshold Pharmaceuticals
TH-302
pancreatic cancer
Threshold Pharma's TH-302 for pancreatic cancer shows positive Phase 2b results
Yahoo/Fly on the Wall
Tue, 02/21/12 - 09:02 am
Threshold Pharmaceuticals
pancreatic cancer
TH-302
Threshold Pharmaceuticals: Up 150% In 4 Months With Room To Grow
Seeking Alpha
Tue, 02/7/12 - 04:41 pm
Threshold Pharmaceuticals
TH-302
hypoxia
pancreatic cancer
Threshold Pharmaceuticals and Merck KGaA Announce Global Agreement to Co-Develop and Commercialize Phase 3 Hypoxia-Targeted Drug TH-302
BioMedReports
Sat, 02/4/12 - 05:01 pm
Threshold Pharmaceuticals
Merck KGaA
TH-302
sarcoma
pancreatic cancer
Infinity Pharma halts pancreatic cancer trial
Mass HiTech
Sat, 01/28/12 - 12:16 pm
Infinity Pharma
IPI-926
saridegib
pancreatic cancer
Infinity Reports New Data from Phase 1b Trial of Saridegib in Patients with Pancreatic Cancer at ASCO-GI
Yahoo/BusinessWire
Sat, 01/21/12 - 12:51 pm
Infinity Pharmaceuticals
saridegib
pancreatic cancer
Cancer Drug Developer NewLink Genetics Gets Push From Analysts
Minyanville
Wed, 12/21/11 - 09:12 pm
analysts
NewLink Genetics
pancreatic cancer
10 Promising Therapeutic Vaccines
Fierce Vaccines
Thu, 10/27/11 - 01:40 pm
vaccines
ICT-107
glioblastoma
ImmunoCellular
VGX-3100
Inovio
cervical cancer
MAGE-A3
GSK
skin cancer
lung cancer
NeuVax
breast cancer
RXi Pharmaceuticals
Antigen Express
AE37
Nexvax2
celiac disease
ImmusanT
ADXS-HPV
head and neck cancer
Advaxis
GI-4000
GlobeImmune
pancreatic cancer
PEV7
Pevion Biotech
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
next ›
last »